SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-036877
Filing Date
2022-07-01
Accepted
2022-07-01 19:19:32
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4136
  Complete submission text file 0001213900-22-036877.txt   5540
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address
O'Loughlin Steve (Reporting) CIK: 0001615840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 221062787